ARTICLE | Company News
FDA approval for Foradil
September 27, 2001 7:00 AM UTC
Novartis (NVS; SWX: NOVN) received FDA approval for its bronchodilator Foradil Aerolizer (formoterol fumarate inhalation powder) to treat bronchoconstriction in patients with chronic obstructive pulmo...